Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Taylor

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|December 1, 1994
Development of a live, oral, attenuated vaccine against El Tor choleraD N Taylor, K P Killeen, D C Hack, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
The Journal of Infectious Diseases|May 24, 2000
Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in PeruD N Taylor, V Cárdenas, J L Sanchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalentR A Kuschner, A F Trofa, R J Thomas, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
The Journal of Infectious Diseases|October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1J R Kenner, T S Coster, D N Taylor, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
Infection and Immunity|November 1, 2006
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coliT S Coster, M K Wolf, E R Hall, et al.
The New England Journal of Medicine|May 27, 1982
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprintingD N Taylor, I K Wachsmuth, Y H Shangkuan, et al.
The Journal of Infectious Diseases|June 1, 1993
Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteersJ L Sanchez, A F Trofa, D N Taylor, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|December 1, 1994
Development of a live, oral, attenuated vaccine against El Tor choleraD N Taylor, K P Killeen, D C Hack, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
The Journal of Infectious Diseases|May 24, 2000
Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in PeruD N Taylor, V Cárdenas, J L Sanchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalentR A Kuschner, A F Trofa, R J Thomas, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
The Journal of Infectious Diseases|October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1J R Kenner, T S Coster, D N Taylor, et al.
Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.
Infection and Immunity|November 1, 2006
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coliT S Coster, M K Wolf, E R Hall, et al.
The New England Journal of Medicine|May 27, 1982
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprintingD N Taylor, I K Wachsmuth, Y H Shangkuan, et al.
The Journal of Infectious Diseases|June 1, 1993
Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteersJ L Sanchez, A F Trofa, D N Taylor, et al.
Pageof 18